Skip to main navigation Skip to search Skip to main content

A comparative study of blood-based KRAS mutation analysis in circulating tumor cells versus circulating plasma DNA to predict primary tumor mutations in lung cancer.

E.K.S. Lim, M.B. Freidin, D.V. Freydina, D. Chudasama, M. Leung, S. Popat, D.G. de Castro, A. Rice, V. Anikin, A.M. Fernandez, A.G. Nicholson

Research output: Contribution to conferenceOther contribution to conferencepeer-review

Original languageEnglish
Publication statusPublished - 20 May 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this